Partners Capital Investment Group LLP acquired a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 49,196 shares of the semiconductor company's stock, valued at approximately $36,738,000. Synopsys makes up approximately 1.3% of Partners Capital Investment Group LLP's holdings, making the stock its 19th biggest position.
A number of other large investors also recently modified their holdings of the company. Sankala Group LLC bought a new stake in shares of Synopsys in the 4th quarter worth approximately $25,000. Elevation Wealth Partners LLC grew its position in shares of Synopsys by 96.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock worth $25,000 after buying an additional 27 shares during the last quarter. Osbon Capital Management LLC bought a new stake in Synopsys in the second quarter valued at $25,000. IMG Wealth Management Inc. purchased a new position in Synopsys during the 2nd quarter valued at $28,000. Finally, Caitong International Asset Management Co. Ltd purchased a new position in Synopsys during the 4th quarter valued at $28,000. 85.47% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on SNPS shares. Piper Sandler raised shares of Synopsys from a "neutral" rating to an "overweight" rating and lifted their target price for the company from $450.00 to $550.00 in a research note on Tuesday, June 23rd. Weiss Ratings restated a "hold (c-)" rating on shares of Synopsys in a report on Monday, June 8th. Citigroup lifted their price objective on Synopsys from $600.00 to $610.00 and gave the company a "buy" rating in a research report on Thursday, May 28th. KeyCorp reiterated an "overweight" rating on shares of Synopsys in a report on Wednesday, August 19th. Finally, Robert W. Baird set a $558.00 target price on Synopsys in a research report on Thursday, May 28th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, Synopsys currently has an average rating of "Moderate Buy" and a consensus target price of $563.59.
Read Our Latest Research Report on SNPS
Synopsys Stock Down 0.8%
NASDAQ:SNPS opened at $394.51 on Tuesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. The firm's 50-day moving average price is $418.53 and its 200-day moving average price is $439.92. The company has a market capitalization of $75.54 billion, a PE ratio of 91.32, a P/E/G ratio of 2.34 and a beta of 1.23. Synopsys, Inc. has a 1-year low of $366.00 and a 1-year high of $615.79.
Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The company had revenue of $2.28 billion during the quarter, compared to analysts' expectations of $2.25 billion. During the same period last year, the company posted $3.67 EPS. Synopsys's revenue was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, equities analysts predict that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
Insider Activity at Synopsys
In related news, CFO Shelagh Glaser sold 3,394 shares of the company's stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. This represents a 19.12% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm's stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares of the company's stock, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by company insiders.
About Synopsys
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.